Bayer files marketing application for larotrectinib

28th August 2018 Uncategorised 0

Bayer has filed a marketing application in Europe seeking approval for larotrectinib as treatment for TRK fusion cancer.

More: Bayer files marketing application for larotrectinib
Source: News